Sidley represented Atia Vision Inc. in its Series E financing led by Cormorant Asset Management with participation by The Capital Partnership, PA MedTech VC Fund, AMED Ventures, and Shifamed Angel investors. Atia Vision Inc., a medical device company, develops modular presbyopia-correcting intraocular lenses to address needs in the intraocular lens replacement market.
The Sidley team was led by Emerging Companies and Venture Capital partner Frank Rahmani (Palo Alto) with the help of managing associate Jake Funk (Palo Alto), senior managing associate Nick DeAngelis (Dallas), and associate Madison Ferraro (Palo Alto). The team also included Food, Drug and Medical Device partner Torrey Cope (Washington, D.C.) and counsel Olivier Goarnisson (Geneva); Securities Enforcement and Regulatory counsel Benjamin L. Nager (New York); Capital Markets partner Daniel A. O'Shea (New York); and Investment Funds staff attorney Shelley Azizi (Los Angeles).
The Sidley team was led by Emerging Companies and Venture Capital partner Frank Rahmani (Palo Alto) with the help of managing associate Jake Funk (Palo Alto), senior managing associate Nick DeAngelis (Dallas), and associate Madison Ferraro (Palo Alto). The team also included Food, Drug and Medical Device partner Torrey Cope (Washington, D.C.) and counsel Olivier Goarnisson (Geneva); Securities Enforcement and Regulatory counsel Benjamin L. Nager (New York); Capital Markets partner Daniel A. O'Shea (New York); and Investment Funds staff attorney Shelley Azizi (Los Angeles).
